07435802 is referenced by 6 patents and cites 1 patents.

The invention provides methods of treatment using humanized immunoglobulins that specifically bind to alpha-4 integrin. The methods are useful for treatment of asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte mediated lung injury.

Title
Humanized anti-VLA4 immunoglobulins
Application Number
11/6808
Publication Number
7435802 (B2)
Application Date
December 8, 2004
Publication Date
October 14, 2008
Inventor
Ted A Yednock
Fairfax
CA, US
Tarran S Jones
Radlett
GB
Jose Saldanha
Enfield
GB
Olivier J Leger
Bertfordshire
GB
Mary M Bendig
West Hampsted
GB
Agent
Crowell & Moring
Assignee
Elan Pharaceuticals
CA, US
IPC
C07K 16/28
View Original Source